Recombinant hepatitis B vaccine (Recombivax HB by Merck) was licensed
On Jul. 23, 1986, the Recombinant hepatitis B vaccine (Recombivax HB by Merck) was licensed. Using recombinant DNA technology, Merck scientists developed a hepatitis B surface antigen subunit vaccine.
Tags:
Source: U.S. Centers for Disease Control and Prevention
Credit:
